Haojiang Lu

Haojiang Lu

Auto-generated profile, based on publicly available information

Haojiang Lu

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SRSanjiv Risal
Sanjiv Risal
MMMaria Manti
Maria Manti
HLHaojiang Lu
Haojiang Lu
RFRomina Fornes
Romina Fornes
HLHenrik Larsson
Henrik Larsson
ESElisabet Stener-Victorin
Elisabet Stener-Victorin
If and how obesity and elevated androgens in women with polycystic ovary syndrome (PCOS) affect their offspring’s psychiatric health is unclear. Using data from Swedish population health registers, we showed that daughters of mothers with PCOS have a 78% increased risk of being diagnosed with anxiety disorders. We next generated a PCOS-like mouse (F0) model induced by androgen exposure during late gestation, with or without diet-induced maternal obesity, and showed that the first generation (F1) female offspring develop anxiety-like behavior, which is transgenerationally transmitted through the female germline into the third generation of female offspring (F3) in the androgenized lineage. In contrast, following the male germline, F3 male offspring (mF3) displayed anxiety-like behavior in the androgenized and the obese lineages. Using a targeted approach to search for molecular targets within the amygdala, we identified five differentially expressed genes involved in anxiety-like behavior in F3 females in the androgenized lineage and eight genes in the obese lineage. In mF3 male offspring, three genes were dysregulated in the obese lineage but none in the androgenized lineage. Finally, we performed in vitro fertilization (IVF) using a PCOS mouse model of continuous androgen exposure. We showed that the IVF generated F1 and F2 offspring in the female germline did not develop anxiety-like behavior, while the F2 male offspring (mF2) in the male germline did. Our findings provide evidence that elevated maternal androgens in PCOS and maternal obesity may underlie the risk of a transgenerational transmission of anxiety disorders in children of women with PCOS.

29 July 2024 in Advanced Science
Verified
Journal Article
Open access
HLHaojiang Lu
Haojiang Lu
HJHong Jiang
Hong Jiang
CLCongru Li
Congru Li
EDEmilie DERISOUD
Emilie DERISOUD
AZAllan Zhao
Allan Zhao
QDQiaolin Deng
Qiaolin Deng
Women with polycystic ovary syndrome (PCOS) exhibit sustained elevation in circulating androgens during pregnancy, an independent risk factor linked to pregnancy complications and adverse outcomes in offspring. Yet, further studies are required to understand the effects of elevated androgens on cell type‐specific placental dysfunction and fetal development. Therefore, a PCOS‐like mouse model induced by continuous androgen exposure is examined. The PCOS‐mice exhibited impaired placental and embryonic development, resulting in mid‐gestation lethality. Co‐treatment with the androgen receptor blocker, flutamide, prevents these phenotypes including germ cell specification. Comprehensive profiling of the placenta by whole‐genome bisulfite and RNA sequencing shows a reduced proportion of trophoblast precursors, possibly due to the downregulation of Cdx2 expression. Reduced expression of Gcm1 , Synb , and Prl3b1 is associated with reduced syncytiotrophoblasts and sinusoidal trophoblast giant cells, impairs placental labyrinth formation. Importantly, human trophoblast organoids exposed to androgens exhibit analogous changes, showing impaired trophoblast differentiation as a key feature in PCOS‐related pregnancy complications. These findings provide new insights into the potential cellular targets for future treatments.

5 September 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MMMaria Manti
Maria Manti
HPHan‐Pin Pui
Han‐Pin Pui
SESonja Edström
Sonja Edström
SRSanjiv Risal
Sanjiv Risal
HLHaojiang Lu
Haojiang Lu
ESElisabet Stener-Victorin
Elisabet Stener-Victorin
Nerve growth factor (NGF) is critical for the development and maintenance of the peripheral sympathetic neurons. NGF is also involved in the ovarian sympathetic innervation and in the development and maintenance of folliculogenesis. Women with the endocrine disorder, polycystic ovary syndrome (PCOS), have an increased sympathetic nerve activity and increased ovarian NGF levels. The role of ovarian NGF excess in the PCOS pathophysiology and in the PCOS‐related features is unclear. Here, using transgenic mice overexpressesing NGF in the ovarian theca cells (17NF mice), we assessed the female embryonic development, and the reproductive and metabolic profile in adult females. Ovarian NGF excess caused growth restriction in the female fetuses, and a delayed gonocyte and primary oocyte maturation. In adulthood, the 17NF mice displayed irregular estrous cycles and altered ovarian expression of steroidogenic and epigenetic markers. They also exhibited an increased sympathetic output with increased circulating dopamine, and metabolic dysfunction reflected by aberrant adipose tissue morphology and function, impaired glucose metabolism, decreased energy expenditure, and hepatic steatosis. These findings indicate that ovarian NGF excess leads to adverse fetal development and to reproductive and metabolic complications in adulthood, mirroring common features of PCOS. This work provides evidence that NGF excess may be implicated in the PCOS pathophysiology.

1 June 2020 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
MWMagdalena Wagner
Magdalena Wagner
MYMasahito Yoshihara
Masahito Yoshihara
IDIyadh Douagi
Iyadh Douagi
ADAnastasios Damdimopoulos
Anastasios Damdimopoulos
SPSarita Panula
Sarita Panula
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
(Abstracted from Nat Commun 2020;11:1147) In the female fetus, oogonia derived from fetal germ cells (FGCs) form primordial follicles that remain dormant until reactivation in the postnatal ovary. The reserve of primordial follicles in the ovarian cortex determines the fertile lifespan, and its depletion marks the beginning of menopause.

27 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AAAngelo Ascani
Angelo Ascani
STSara Torstensson
Sara Torstensson
SRSanjiv Risal
Sanjiv Risal
HLHaojiang Lu
Haojiang Lu
GEGustaw Eriksson
Gustaw Eriksson
ESElisabet Stener-Victorin
Elisabet Stener-Victorin
Variations in B cell numbers are associated with polycystic ovary syndrome (PCOS) through unknown mechanisms. Here we demonstrate that B cells are not central mediators of PCOS pathology and that their frequencies are altered as a direct effect of androgen receptor activation. Hyperandrogenic women with PCOS have increased frequencies of age-associated double-negative B memory cells and increased levels of circulating immunoglobulin M (IgM). However, the transfer of serum IgG from women into wild-type female mice induces only an increase in body weight. Furthermore, RAG1 knock-out mice, which lack mature T- and B cells, fail to develop any PCOS-like phenotype. In wild-type mice, co-treatment with flutamide, an androgen receptor antagonist, prevents not only the development of a PCOS-like phenotype but also alterations of B cell frequencies induced by dihydrotestosterone (DHT). Finally, B cell-deficient mice, when exposed to DHT, are not protected from developing a PCOS-like phenotype. These results urge further studies on B cell functions and their effects on autoimmune comorbidities highly prevalent among women with PCOS. Summary: Androgen receptor activation alters B cell frequencies and functionality as the transfer of human PCOS IgG increase weight in female mice. Lack of B cells does not protect from the development of a PCOS phenotype, suggesting an unrecognized role for B cells in PCOS autoimmune comorbidities. Graphical

17 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTina Gorsek Sparovec
Tina Gorsek Sparovec
GEGustaw Eriksson
Gustaw Eriksson
CLCongru Li
Congru Li
RSRutger Schutten
Rutger Schutten
HLHaojiang Lu
Haojiang Lu
ESElisabet Stener-Victorin
Elisabet Stener-Victorin
Summary: Polycystic ovary syndrome (PCOS) is associated with skeletal muscle insulin resistance, fibrosis, and lipotoxicity, yet the cellular origins remain unknown. Here, we present a comprehensive cellular atlas of skeletal muscle from hyperinsulinemic and hyperandrogenic women with PCOS and controls of similar age, weight, and BMI. Analysis of 72,247 nuclei from 19 biopsies revealed cell-type-specific dysregulation in PCOS, with fiber-type-specific metabolic impairment, converging with pro-fibrotic reprogramming of fibro-adipogenic progenitors (FAPs) and enhanced FAP-myofiber crosstalk, characterized by enhanced collagen and laminin signaling. Metformin intervention for 16-weeks selectively reversed PCOS-associated transcriptional dysregulation in FAPs, revealing heterogeneous cellular responses in skeletal muscle. In vitro , PCOS myotubes retained metabolic dysfunction, yet show normalized glucose responsiveness, indicating plasticity despite metabolic memory. Systemic hyperinsulinemia and hyperandrogenemia correlated with transcriptional signatures in muscle fibers and FAPs, linking endocrine imbalance to pro-fibrotic remodeling. These findings identify novel therapeutic targets beyond conventional insulin-sensitizing approaches. Highlights: - First single-nuclei atlas of human skeletal muscle in women with PCOS - FAPs subpopulations display activated pro-fibrotic phenotype - Metformin selectively targets distinct cell populations - Hyperinsulinemia and hyperandrogenemia correlate with transcriptional signatures of skeletal muscle fibers and FAPs